![John Trizzino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Trizzino
No open positions remaining
Net worth: 897 534 $ as of 31/07/2026
Profile
Mr. John J. Trizzino is a CFO, EVP, Chief Commercial & Business Officer at Novavax, Inc. Mr. Trizzino was previously employed as a Chief Executive Officer & Director by ImmunoVaccine, Inc., a Vice President-Vaccine Franchise by MedImmune LLC, a Vice President-Business Development by ID Biomedical Corp., and a Vice President-Business Development by Henry Schein, Inc. He also served on the board at Tech Council of Maryland, Inc. He received his undergraduate degree from Long Island University and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC. 0.07% | 23/04/2026 | 122,614 ( 0.07% ) | 897 534 $ | 31/07/2026 |
Latest news about John Trizzino
Former positions of John Trizzino
| Companies | Position | End |
|---|---|---|
| NOVAVAX, INC. | Director of Finance/CFO | 16/08/2021 |
| IMV INC. | Chief Executive Officer | 01/09/2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06/09/2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Corporate Officer/Principal | 01/01/2009 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/01/2009 |
Training of John Trizzino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Henry Schein, Inc.
 Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Provides membership association services for technology and life science communities | Commercial Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- John Trizzino
